Neuraxis, INC - NRXS

Sector: Healthcare · Industry: Electromedical & Electrotherapeutic Apparatus
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$6.872M
QoQ value delta ($000)
+$4.435M (+181.99%)
Implied price effect (QoQ)
+42.38%
Shares
Total shares
1,572,533
QoQ shares delta
+778,538 (+98.05%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NRXS)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 32 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
AIGH Capital Management LLC 1,816 400,000 0.44%
Rosalind Advisors, Inc. 1,039 286,138 0.37%
MONEY CONCEPTS CAPITAL CORP 1,010 222,605 0.06%
Panoramic Capital, LLC 749 165,000 0.4%
VANGUARD GROUP INC 660 145,562 0.0%
PARSONS CAPITAL MANAGEMENT INC/RI 529 116,726 0.03%
GEODE CAPITAL MANAGEMENT, LLC 343 75,653 0.0%
UBS Group AG 221 48,830 0.0%
STATE STREET CORP 138 30,537 0.0%
NORTHERN TRUST CORP 94 20,746 0.0%
ROYAL BANK OF CANADA 69 15,101 0.0%
Wealthcare Advisory Partners LLC 68 15,188 0.0%
XTX Topco Ltd 54 12,068 0.0%
LPL Financial LLC 45 10,000 0.0%
MORGAN STANLEY 26 5,802 0.0%
Tower Research Capital LLC (TRC) 6 1,502 0.0%
Ulland Investment Advisors, LLC 5 1,000 0.0%
BANK OF AMERICA CORP /DE/ 0 75 0.0%